Department of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, Minnesota 55905, USA.
Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.
J Clin Endocrinol Metab. 2022 Nov 23;107(11):3137-3143. doi: 10.1210/clinem/dgac464.
Diabetic ketoacidosis (DKA) in pregnancy is an obstetric emergency with risk of maternofetal death.
This work aimed to evaluate DKA events in pregnant women admitted to our inpatient obstetric service, and to examine associated clinical risk factors, presentation, and pregnancy outcomes.
A retrospective cohort study was conducted at the Mayo Clinic, Rochester, Minnesota, USA, and included women aged 17 to 45 years who were treated for DKA during pregnancy between January 1, 2004 and December 31, 2021. Main outcome measures included maternal and fetal death along with a broad spectrum of maternal and fetal pregnancy outcomes.
A total of 71 DKA events were identified in 58 pregnancies among 51 women, 48 (82.8%) of whom had type 1 diabetes. There were no maternal deaths, but fetal demise occurred in 10 (17.2%) pregnancies (6 miscarriages and 4 stillbirths). Maternal social stressors were frequently present (n = 30, 51.0%), and glycemic control was suboptimal (median first trimester glycated hemoglobin A1c = 9.0%). Preeclampsia was diagnosed in 17 (29.3%) pregnancies. Infants born to women with DKA were large for gestational age (n = 16, 33.3%), suffered from neonatal hypoglycemia (n = 29, 60.4%) and required intensive care unit admission (n = 25, 52.1%).
DKA is associated with a high rate of maternofetal morbidity and fetal loss. Prenatal education strategies for women with diabetes mellitus should include a strong focus on DKA prevention, and clinicians and patients should have a high index of suspicion for DKA in all pregnant women who present with symptoms that could be attributed to this condition.
妊娠糖尿病酮症酸中毒(DKA)是一种产科急症,可导致母婴死亡。
本研究旨在评估在我院住院产科接受治疗的妊娠妇女的 DKA 事件,并探讨相关临床危险因素、临床表现和妊娠结局。
本研究为美国明尼苏达州罗切斯特市梅奥诊所的一项回顾性队列研究,纳入 2004 年 1 月 1 日至 2021 年 12 月 31 日期间因妊娠期间 DKA 接受治疗的年龄在 17 至 45 岁之间的女性。主要结局指标包括母婴死亡以及广泛的母婴妊娠结局。
在 51 名女性的 58 例妊娠中,共发现 71 例 DKA 事件,其中 48 例(82.8%)患有 1 型糖尿病。无产妇死亡,但有 10 例(17.2%)妊娠发生胎儿死亡(6 例流产,4 例死产)。经常存在产妇社会应激源(n=30,51.0%),血糖控制不理想(中位孕早期糖化血红蛋白 A1c=9.0%)。17 例(29.3%)妊娠诊断为子痫前期。患有 DKA 的女性所生婴儿巨大儿(n=16,33.3%),新生儿低血糖(n=29,60.4%),需要入住重症监护病房(n=25,52.1%)。
DKA 与母婴发病率和胎儿丢失率高有关。糖尿病女性的产前教育策略应特别强调 DKA 的预防,所有出现可能归因于这种情况的症状的孕妇,临床医生和患者都应高度怀疑 DKA。